Share on StockTwits

Codexis (NASDAQ:CDXS) released its earnings data on Wednesday. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.10) by $0.07, American Banking reports. The company had revenue of $7.10 million for the quarter, compared to the consensus estimate of $10.00 million. During the same quarter in the prior year, the company posted ($0.25) earnings per share. The company’s quarterly revenue was down 38.3% on a year-over-year basis.

Shares of Codexis (NASDAQ:CDXS) traded up 0.66% during mid-day trading on Wednesday, hitting $1.53. The stock had a trading volume of 44,106 shares. Codexis has a one year low of $1.24 and a one year high of $2.89. The stock’s 50-day moving average is $1.85 and its 200-day moving average is $1.70. The company’s market cap is $58.7 million.

Codexis, Inc provides biocatalyst and fermentation processes and products. The Company provides its customers research and development services, biocatalysts and fermentation strains, synthetic and natural products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.